US6837501039 - OPNT (XNAS)
OPIANT PHARMACEUTICALS INC Acción
Sin cotización
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | 38,68 % |
Company Profile for OPIANT PHARMACEUTICALS INC Share
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
Company Data for OPIANT PHARMACEUTICALS INC Share
Name OPIANT PHARMACEUTICALS INC
Company Opiant Pharmaceuticals, Inc.
Symbol OPNT
Website https://www.opiant.com
Primary Exchange
NASDAQ
ISIN US6837501039
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Roger Crystal M.D.
Market Capitalization 109 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 233 Wilshirre Boulevard, 90401 Santa Monica
IPO Date 2007-06-04
Stock Splits
Date | Split |
---|---|
31.12.2014 | 1:100 |
ID Changes
Date | From | To |
---|---|---|
22.01.2016 | LLTP | OPNT |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | OPNT |
More Shares
Investors who OPIANT PHARMACEUTICALS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.